Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma

By Abacioglu Ufuk   Caglar Hale   Yumuk Perran   Akgun Zuleyha   Atasoy Beste   Sengoz Meric  

Journal of Neuro-Oncology, Vol. 103, Iss. 3, 2011-07 ,pp. : 585-593

Springer Publishing Company

Access to resources Recommend Favorite

Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma

By Su Ying-Wen   Chang Ming-Chih   Chiang Ming-Fu   Hsieh Ruey-Kuen  

Journal of Neuro-Oncology, Vol. 71, Iss. 3, 2005-02 ,pp. : 315-318

Springer Publishing Company

Access to resources Recommend Favorite

Past, Present, and Future Strategies in the Treatment of High-Grade Glioma in Children

By Broniscer Alberto  

Cancer Investigation, Vol. 24, Iss. 1, 2006-03 ,pp. : 77-81

Informa Healthcare

Access to resources Recommend Favorite

Sitimagene ceradenovec: a gene-based drug for the treatment of operable high-grade glioma

By van Putten Erik HP   Dirven Clemens MF   van den Bent Martin J   Lamfers Martine LM  

Future Oncology, Vol. 6, Iss. 11, 2010-11 ,pp. : 1691-1710

Future Medicine

Access to resources Recommend Favorite

Re-irradiation and bevacizumab in recurrent high-grade glioma: an effective treatment option

By Flieger Maya   Ganswindt Ute   Schwarz Silke   Kreth Friedrich-Wilhelm   Tonn Jörg-Christian   Fougère Christian   Ertl Lorenz   Linn Jennifer   Herrlinger Ulrich   Belka Claus   Niyazi Maximilian  

Journal of Neuro-Oncology, Vol. 117, Iss. 2, 2014-04 ,pp. : 337-345

Springer Publishing Company

Access to resources Recommend Favorite